need help with your account or subscription? click here to email us (or see the contact page)
join telegramNEW! discord
jump to exam page:
search for anything ⋅ score predictor (โ€œpredict me!โ€)

Retired NBME 25 Answers

nbme25/Block 1/Question#2 (reveal difficulty score)
New reagents are being designed to treat ...
T lymphocytes ๐Ÿ” / ๐Ÿ“บ / ๐ŸŒณ / ๐Ÿ“–
tags:

 Login (or register) to see more


 +1  upvote downvote
submitted by โˆ—shak360(20)
get full access to all contentpick a username

GVHD is due to DONOR T lymphocytes recognizing and targeting recipient cells (usually GI, skin, and liver) [diarrhea, maculopapular rash, hepatomegaly, jaundice]. This also means that this is a Type IV hypersensitivity such as contact dermatitis (poison ivy or a nickel allergy) and the PPD test. Sometimes this is taken advantage of (GVHD is usually seen in bone marrow transplants) in the scenario of bone marrow transplants for leukemia patients where we can yield a "graft-versus-tumor" effect.

get full access to all contentpick a username
shak360  Also see this question in block 2. +



Must-See Comments from nbme25


search for anything NEW!